Homozygous Familial Hypercholesterolemia in Canada-Reference-Cited by-同舟云学术

Homozygous Familial Hypercholesterolemia in Canada

Published:2023-05 Issue:3 Volume:2 Page:100309
ISSN:2772-963X
Container-title:JACC: Advances
language:en
Short-container-title:JACC: Advances

Author:

Brown Leslie,Ruel Isabelle,Baass Alexis,Bergeron Jean,Brunham Liam R.,Cermakova Lubomira,Couture Patrick,Gaudet Daniel,Francis Gordon A.,Hegele Robert A.,Iatan Iulia,Mancini G.B. John,McCrindle Brian W.,Ransom Thomas,Sherman Mark H.,McPherson Ruth,Genest Jacques

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Reference31 articles.

1. Orphanet report series: prevalence, incidence or reported number of published cases listed in alphabetical order of disease;Consortium,2022

2. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province;Moorjani;Arteriosclerosis,1989

3. Phenotypical, clinical, and molecular aspects of adults and children with homozygous familial hypercholesterolemia in iberoamerica;Alves;Arterioscler Thromb Vasc Biol,2020

4. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

5. Evidence for improved survival with treatment of homozygous familial hypercholesterolemia;Belanger;Curr Opin Lipidol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous determination of Rosuvastatin calcium and Bempedoic acid in fixed-dose combination pharmaceutical dosage forms using RP-HPLC method;Microchemical Journal;2024-10

2. Lipid Disorders and Pregnancy;Endocrinology and Metabolism Clinics of North America;2024-09

3. Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia;Journal of Clinical Lipidology;2024-03

4. Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study;Atherosclerosis;2024-03

5. It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States;Global Heart;2024